Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Original Research Article


Anti-inflammatory Effects of (-)-Epicatechin in Lipopolysaccharide-Stimulated Raw 264.7 Macrophages

 

Hai Wang1* and Zhi-Ran Cao2

1Medical Department, The Second Central Hospital  of  Baoding City, Hebei 072750, 2Department of Immunology, School of Basic Medicine, Hebei University Health Science Center, Hebei 071000, China

 

*For correspondence: Email: wanghai201311@163.com; Tel: +86-312-3966325

 

Received: 29 April 2014                                                                          Revised accepted: 15 August 2014

 

Tropical Journal of Pharmaceutical Research, September 2014; 13(9): 1415-1419

http://dx.doi.org/10.4314/tjpr.v13i9.6   

Abstract

 

Purpose: To investigate the protective effects of (-)-epicatechin on lipopolysaccharide (LPS)-induced inflammation in Raw 264.7 murine macrophages and the possible underlying mechanisms.

Methods: The effects of epicatechin on LPS-stimulated production of inflammatory mediators in Raw 264.7 cells were evaluated by enzyme-linked immunosorbent assay.

Results: Epicatechin in doses of 5, 25 and 50 μM remarkably (p < 0.05) inhibited the production of pro-inflammatory mediators including nitric oxide (NO) and prostaglandin E2 (PGE2), as well as the production of pro-inflammatory cytokines including tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 in LPS-induced Raw 264.7 macrophages.

Conclusion: The results suggest that epicatechin can inhibit inflammatory response and may be a potential therapeutic candidate for the treatment of chronic inflammatory diseases.

 

Key words: Inflammation, Epicatechin, Cytokines, Nitric oxide, Prostaglandin E2, Macrophages

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net